The global Percutaneous Coronary Intervention (PCI) Devices Market Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Type (Coronary Catheters, Coronary Guidewires, Coronary Stents, Accessories), By End-User (Hospitals, Ambulatory Surgical Centers, Others).
The Percutaneous Coronary Intervention (PCI) Devices Market in 2024 reflects the dynamic landscape of interventional cardiology, offering advanced technologies and devices for the diagnosis and treatment of coronary artery disease (CAD) through minimally invasive procedures. Percutaneous coronary intervention, commonly known as angioplasty or stenting, involves the insertion of catheters and specialized devices into the coronary arteries to restore blood flow and alleviate myocardial ischemia. The PCI devices market encompasses a wide range of products including coronary stents, balloon catheters, guidewires, atherectomy devices, and intravascular imaging systems, tailored to the diverse needs of interventional cardiologists and their patients. With a growing prevalence of CAD and acute coronary syndromes worldwide, coupled with advancements in device technology, drug-eluting stents, and adjunctive pharmacotherapy, the PCI devices market witnesses continuous innovation and clinical adoption, driving improvements in procedural outcomes, patient safety, and long-term cardiovascular health.
The global Percutaneous Coronary Intervention (PCI) Devices Industry is highly competitive with a large number of companies focusing on niche market segments. Amidst intense competitive conditions, Percutaneous Coronary Intervention (PCI) Devices Companies are investing in new product launches and strengthening distribution channels. Key companies operating in the Percutaneous Coronary Intervention (PCI) Devices Industry include- Abbott Laboratories, Asahi Intecc Co. Ltd, B. Braun Melsungen AG, Biosensors International Group Ltd, BIOTRONIK, Boston Scientific Corp, Comed B.V., Cook Medical, Medtronic Plc, Meril Life Sciences Pvt. Ltd.
A prominent trend in the Percutaneous Coronary Intervention (PCI) Devices Market is the continuous technological advancements seen in PCI devices. These advancements include the development of next-generation stents, improved drug-eluting stents (DES), bioresorbable stents, and innovative catheter technologies. The integration of advanced materials, coatings, and delivery systems has enhanced the efficacy, safety, and durability of PCI devices, leading to better patient outcomes and expanding the scope of minimally invasive cardiovascular interventions.
The primary driver propelling the Percutaneous Coronary Intervention (PCI) Devices Market is the increasing prevalence of cardiovascular diseases (CVDs), including coronary artery disease (CAD) and myocardial infarction (MI). Factors such as sedentary lifestyles, unhealthy dietary habits, rising obesity rates, and aging populations contribute to the growing burden of CVDs globally. As PCI procedures are widely used for the treatment of obstructive CAD and acute coronary syndromes, the rising incidence of these conditions drives the demand for PCI devices, including stents, balloons, guidewires, and catheters.
An opportunity in the Percutaneous Coronary Intervention (PCI) Devices Market lies in the expansion of PCI procedures in emerging markets. With increasing awareness about cardiovascular health, improving healthcare infrastructure, and rising disposable incomes in emerging economies, there is a growing demand for advanced cardiovascular interventions, including PCI procedures. Companies operating in the PCI devices segment can capitalize on this opportunity by expanding their presence in emerging markets, offering innovative PCI devices, establishing strategic partnerships with local healthcare providers, and conducting educational initiatives to train healthcare professionals. This expansion can not only drive revenue growth but also contribute to better patient access to essential cardiovascular treatments in developing regions.
Coronary stents emerge as the category experiencing the fastest growth within the percutaneous coronary intervention (PCI) devices market. This surge is propelled by several crucial factors. Firstly, coronary stents play a pivotal role in the treatment of coronary artery disease by providing mechanical support to keep narrowed or blocked arteries open and improve blood flow to the heart muscle. With the increasing prevalence of coronary artery disease worldwide, driven by factors such as aging populations and lifestyle-related risk factors, there is a growing demand for coronary stents as a primary treatment modality for patients with symptomatic ischemic heart disease. Secondly, advancements in stent technology, including drug-eluting stents (DES) and bioresorbable stents, have led to improved clinical outcomes, reduced rates of restenosis, and enhanced patient safety, driving the adoption of coronary stents in PCI procedures. Additionally, the expanding utilization of minimally invasive PCI techniques and the shift towards same-day discharge protocols in hospitals and ambulatory surgical centers further contribute to the increased demand for coronary stents. Moreover, the availability of a wide range of coronary stent designs and sizes, along with the introduction of innovative biocompatible materials and coating technologies, enhances the versatility and effectiveness of coronary stent implantation in diverse patient populations. As cardiovascular care continues to evolve, coronary stents remain at the forefront of innovation and growth in the PCI devices market, offering new opportunities for improving patient outcomes and quality of life for individuals with coronary artery disease.
By Type
Coronary Catheters
Coronary Guidewires
Coronary Stents
Accessories
By End-User
Hospitals
Ambulatory Surgical Centers
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Abbott Laboratories
Asahi Intecc Co. Ltd
B. Braun Melsungen AG
Biosensors International Group Ltd
BIOTRONIK
Boston Scientific Corp
Comed B.V.
Cook Medical
Medtronic Plc
Meril Life Sciences Pvt. Ltd
* List not Exhaustive
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Percutaneous Coronary Intervention (PCI) Devices Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Percutaneous Coronary Intervention (PCI) Devices Industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Percutaneous Coronary Intervention (PCI) Devices Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Percutaneous Coronary Intervention (PCI) Devices Market Size Outlook, $ Million, 2021 to 2030
3.2 Percutaneous Coronary Intervention (PCI) Devices Market Outlook by Type, $ Million, 2021 to 2030
3.3 Percutaneous Coronary Intervention (PCI) Devices Market Outlook by Product, $ Million, 2021 to 2030
3.4 Percutaneous Coronary Intervention (PCI) Devices Market Outlook by Application, $ Million, 2021 to 2030
3.5 Percutaneous Coronary Intervention (PCI) Devices Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Percutaneous Coronary Intervention (PCI) Devices Industry
4.2 Key Market Trends in Percutaneous Coronary Intervention (PCI) Devices Industry
4.3 Potential Opportunities in Percutaneous Coronary Intervention (PCI) Devices Industry
4.4 Key Challenges in Percutaneous Coronary Intervention (PCI) Devices Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Percutaneous Coronary Intervention (PCI) Devices Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Percutaneous Coronary Intervention (PCI) Devices Market Outlook by Segments
7.1 Percutaneous Coronary Intervention (PCI) Devices Market Outlook by Segments, $ Million, 2021- 2030
By Type
Coronary Catheters
Coronary Guidewires
Coronary Stents
Accessories
By End-User
Hospitals
Ambulatory Surgical Centers
Others
8 North America Percutaneous Coronary Intervention (PCI) Devices Market Analysis and Outlook To 2030
8.1 Introduction to North America Percutaneous Coronary Intervention (PCI) Devices Markets in 2024
8.2 North America Percutaneous Coronary Intervention (PCI) Devices Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Percutaneous Coronary Intervention (PCI) Devices Market size Outlook by Segments, 2021-2030
By Type
Coronary Catheters
Coronary Guidewires
Coronary Stents
Accessories
By End-User
Hospitals
Ambulatory Surgical Centers
Others
9 Europe Percutaneous Coronary Intervention (PCI) Devices Market Analysis and Outlook To 2030
9.1 Introduction to Europe Percutaneous Coronary Intervention (PCI) Devices Markets in 2024
9.2 Europe Percutaneous Coronary Intervention (PCI) Devices Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Percutaneous Coronary Intervention (PCI) Devices Market Size Outlook by Segments, 2021-2030
By Type
Coronary Catheters
Coronary Guidewires
Coronary Stents
Accessories
By End-User
Hospitals
Ambulatory Surgical Centers
Others
10 Asia Pacific Percutaneous Coronary Intervention (PCI) Devices Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Percutaneous Coronary Intervention (PCI) Devices Markets in 2024
10.2 Asia Pacific Percutaneous Coronary Intervention (PCI) Devices Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Percutaneous Coronary Intervention (PCI) Devices Market size Outlook by Segments, 2021-2030
By Type
Coronary Catheters
Coronary Guidewires
Coronary Stents
Accessories
By End-User
Hospitals
Ambulatory Surgical Centers
Others
11 South America Percutaneous Coronary Intervention (PCI) Devices Market Analysis and Outlook To 2030
11.1 Introduction to South America Percutaneous Coronary Intervention (PCI) Devices Markets in 2024
11.2 South America Percutaneous Coronary Intervention (PCI) Devices Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Percutaneous Coronary Intervention (PCI) Devices Market size Outlook by Segments, 2021-2030
By Type
Coronary Catheters
Coronary Guidewires
Coronary Stents
Accessories
By End-User
Hospitals
Ambulatory Surgical Centers
Others
12 Middle East and Africa Percutaneous Coronary Intervention (PCI) Devices Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Percutaneous Coronary Intervention (PCI) Devices Markets in 2024
12.2 Middle East and Africa Percutaneous Coronary Intervention (PCI) Devices Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Percutaneous Coronary Intervention (PCI) Devices Market size Outlook by Segments, 2021-2030
By Type
Coronary Catheters
Coronary Guidewires
Coronary Stents
Accessories
By End-User
Hospitals
Ambulatory Surgical Centers
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Abbott Laboratories
Asahi Intecc Co. Ltd
B. Braun Melsungen AG
Biosensors International Group Ltd
BIOTRONIK
Boston Scientific Corp
Comed B.V.
Cook Medical
Medtronic Plc
Meril Life Sciences Pvt. Ltd
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Type
Coronary Catheters
Coronary Guidewires
Coronary Stents
Accessories
By End-User
Hospitals
Ambulatory Surgical Centers
Others
The global Percutaneous Coronary Intervention (PCI) Devices Market is one of the lucrative growth markets, poised to register a 6.1% growth (CAGR) between 2024 and 2030.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Abbott Laboratories, Asahi Intecc Co. Ltd, B. Braun Melsungen AG, Biosensors International Group Ltd, BIOTRONIK, Boston Scientific Corp, Comed B.V., Cook Medical, Medtronic Plc, Meril Life Sciences Pvt. Ltd
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume